NanoViricides Inc. (NNVC)

[arvitar]

"Cease and desist" from what?

The company will have enough cash at the end of this month to only support "current operations" for another 11 months, and isn't close to do doing anything that generates revenue.

And that's only of Boniuk doesn't collect his $5M for his series C convertible debenture that's due on June 30, 2018.

Seymour still hasn't even picked a lead, after 13 years and running up a $75M deficit.

Wisconsin, Pittsburgh, Baylor, St Jude, and everything else from last year has mysteriously gone POOF!!!


Seymour even let the company's indentifying "Nanoviricides" trademark expire, rather than pay its a couple hundred bucks to have it renewed, for godsake.

From the company's own most recent 10-Q:

The Company has an accumulated deficit at March 31, 2017 of $72,570,721. In addition, the Company has not generated any revenues and no revenues are anticipated in the foreseeable future. Since May 2005, the Company has been engaged exclusively in research and development activities focused on developing targeted antiviral drugs. The Company has not yet commenced any product commercialization. Such losses are expected to continue for the foreseeable future and until such time, if ever, as the Company is able to attain sales levels sufficient to support its operations. There can be no assurance that the Company will achieve or maintain profitability in the future.

P.9 http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=12069535-842-212921&type=sect&TabIndex=2&companyid=726365&ppu=%252fdefault.aspx%253fcik%253d1379006